K

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Research Associate 1/2 - Analytical Development

Bioprocess & BiomanufacturingUpdated on Nov 14
Full-timeMorrisville, NC, USANo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree in Biochemistry, Chemistry, Molecular Biology, or another science field, with relevant course completion; an equivalent combination of education and experience is acceptable.
  • At least 2 years of industry experience.
  • Strong verbal, written, and interpersonal communication skills.
  • Ability to work independently and collaboratively; self-motivated and organized.
  • Ability to exercise discretion and independent judgment.
  • Ability and willingness to work in a fast-paced startup environment.
  • Ability to stand, sit, and use laboratory equipment for extended periods; some lifting may be required.
  • Ability to handle and dispose of chemicals or biological materials in accordance with proper procedures.

Responsibilities

  • Independently execute multiple analytical test methods for AAV in-process and drug-substance genetic material.
  • Independently create summaries of results.
  • Document all activities in accordance with company procedures and GDP requirements.
  • Manage assigned activities, equipment, inventory, reagents, and projects of the analytical development lab.
  • Assist other scientists with sample and solution preparation as required.
  • Perform other duties as necessary.

Desired Qualifications

  • Coursework in Analytical Chemistry is preferred.
  • Capillary electrophoresis experience is strongly preferred.

About the Company

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Kriya Therapeutics develops gene therapies for widespread diseases and monetizes these programs through licensing and collaboration agreements. Its gene therapies target genetic or biological drivers of conditions such as Geographic Atrophy, Diabetic Retinopathy, and NASH, with a focus on ophthalmology. The company advances programs by partnering with biotech and pharma companies to secure upfront payments, milestones, and potential royalties. Its goal is to become a leading gene therapy biopharmaceutical company by delivering safe, effective treatments and generating revenue through collaborations and eventual product sales.

Company size
201-500
Company stage
Series D
Total funding
$920.5M
Headquarters
Morrisville, NC
Founded
2019

Recently Posted Jobs

Explore more opportunities at Kriya Therapeutics

See more jobs